Ets-1 transcription is required in tissue factor driven microvessel formation and stabilization

Area of Science:

• Molecular biology
• Cell signaling
• Angiogenesis research

Background:

• Tissue factor (TF) is known to initiate blood coagulation and act as an intracellular signaling receptor.
• TF signaling regulates gene transcription and protein translation, and TF-induced neovascularization is driven by CCL2 expression.

Purpose of the Study:

• To investigate the signaling mechanisms by which TF promotes microvessel formation.
• To identify downstream effectors of TF signaling in angiogenesis.

Main Methods:

• Utilized TF-siRNA to inhibit TF expression and assess its impact on downstream signaling molecules.
• Investigated the role of Ets-1 activation in TF-induced microvessel formation.
• Analyzed the signaling pathway involving ERK1/2, Ets-1, and CCL2 gene expression.

Main Results:

• TF inhibition significantly reduced Ets-1 expression and DNA binding, abrogating microvessel formation.
• Ets-1 activation rescued TF inhibition effects, confirming its critical role in TF-induced angiogenesis.
• TF signaling activates ERK1/2 to upregulate Ets-1, which then drives CCL2 gene expression and microvessel formation.

Conclusions:

• Endothelial cell TF signals through the ERK1/2 and Ets-1 pathway.
• This pathway is essential for triggering microvessel formation via CCL2 gene expression.